Drug Update Quizz 9Created on December 04, 2021MaribavirFDA has recently approved maribavir as the first drug for treating adults and pediatric patients (12 years of age and older and weighing at least 35 kilograms) with post-transplant cytomegalovirus (CMV) infection/disease that does not respond (with or without genetic mutations that cause resistance) to available antiviral treatment for CMV. The mechanism of action of maribavir is ? Inhibits DNA polymerase (UL54 gene) ATP competitor of viral UL97 kinase Inhibits virion assembly DNA terminal transferase complex binding Maribavir is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents. Change/Click on page numbers below for next Question Pages: 1 2 3 4 5
